intracellular molecular pathway
Showing 1 - 25 of 8,894
TNBC - Triple-Negative Breast Cancer Trial (A1:SG with SHR3680, A2:SG, B1:SG with SHR1210)
Not yet recruiting
- TNBC - Triple-Negative Breast Cancer
- A1:SG with SHR3680
- +7 more
- (no location specified)
Jun 23, 2023
Efficacy of Trastuzumab Therapy for HER2-positive Breast Cancer
Active, not recruiting
- HER2-positive Breast Cancer
- RNA sequencing
- +3 more
-
Walnut, California
- +3 more
Sep 13, 2021
Heart Failure, Ischemic Cardiomyopathy Trial in Roma (Blood sample)
Active, not recruiting
- Heart Failure
- Ischemic Cardiomyopathy
- Blood sample
-
Roma, ItalyFondazione Policlinico Gemelli
Feb 27, 2023
Molecular Diagnosis of Systemic Autoinflammatory Diseases
Not yet recruiting
- Inflammatory Disease
- +4 more
-
Paris, FranceTrousseau Hospital
May 23, 2022
Recurrent Endometrial Carcinoma, Recurrent Ovarian Carcinoma Trial (Biopsy, Biospecimen Collection, Bone Marrow Aspiration and
Not yet recruiting
- Recurrent Endometrial Carcinoma
- Recurrent Ovarian Carcinoma
- Biopsy
- +5 more
- (no location specified)
Sep 29, 2022
Colo-rectal Cancer, Molecular Pathway Deregulation Trial in Seongnam-si
Active, not recruiting
- Colo-rectal Cancer
- Molecular Pathway Deregulation
-
Seongnam-si, Gyeonggi-do, Korea, Republic ofSeoul National University Bundang Hospital
May 3, 2022
Solid Tumors Trial in Toronto (Afatinib)
Active, not recruiting
- Solid Tumors
-
Toronto, Ontario, CanadaPrincess Margaret Cancer Centre
May 12, 2022
Colorectal Cancer, KRAS Wildtype, NRAS Wildtype Trial in Toronto (Trametinib, Panitumumab)
Completed
- Colorectal Cancer
- +3 more
-
Toronto, Ontario, CanadaPrincess Margaret Cancer Centre
May 12, 2022
Pancreatic Cancer, Adenocarcinoma Trial in Canada (GSK2256098, Trametinib)
Active, not recruiting
- Pancreatic Cancer
- Adenocarcinoma
-
Hamilton, Ontario, Canada
- +3 more
May 12, 2022
Cancer Target Therapy Efficacy
Active, not recruiting
- Cancer
- RNA sequencing
- +5 more
-
Walnut, California
- +6 more
Sep 13, 2021
TNBC - Triple-Negative Breast Cancer Trial (Alkaline Glucosodiene Molecules)
Not yet recruiting
- TNBC - Triple-Negative Breast Cancer
- Alkaline Glucosodiene Molecules
- (no location specified)
Jul 14, 2023
RASopathy, Costello Syndrome, Cardio-Facio-Cutaneous Syndrome Trial in Roma (Molecular characterization of solid tumor in
Recruiting
- RASopathy
- +3 more
- Molecular characterization of solid tumor in RASopathies
-
Roma, ItalyDepartment of Woman and Child Health and Public Health, Fondazio
Feb 27, 2023
Cardiac Tissue in Postnatal Development
Recruiting
- Congenital Heart Disease
- Tetralogy of Fallot
-
Atlanta, GeorgiaEmory University School of Medicine
Jun 21, 2022
Sebaceous Cell Tumor of Eyelid Trial in Roma (exome sequencing (retrospective) and exome and methylome sequencing (prospective))
Recruiting
- Sebaceous Cell Tumor of Eyelid
- exome sequencing (retrospective) and exome and methylome sequencing (prospective)
-
Roma, Rome, ItalyGustavo Savino
Oct 8, 2023
Hyperferritinemia Candidate Gene
Recruiting
- Hyperferritinemia
- Genetic analysis
-
Monza, MB, ItalyCentre for Rare Disease - Disorders of Iron Metabolism, ASST-Mon
Jan 17, 2023
Brain Derived Neurotrophic Factor rs6265 Gene Polymorphism With
Not yet recruiting
- Epilepsy
- Genotyping by Real Time PCR
- (no location specified)
Oct 14, 2021
Metastatic Lung Cancer, Metastatic Gastrointestinal Cancer Trial (FoundationOne® Liquid CDx Assay, Standard of Care Diagnostic
Not yet recruiting
- Metastatic Lung Cancer
- Metastatic Gastrointestinal Cancer
- FoundationOne® Liquid CDx Assay
- Standard of Care Diagnostic Pathway
- (no location specified)
May 11, 2023
TNBC - Triple-Negative Breast Cancer Trial in Shanghai (A1: Pyrotinib with Capecitabine, A2: nab-paclitaxel, B1: everolimus with
Recruiting
- TNBC - Triple-Negative Breast Cancer
- A1: Pyrotinib with Capecitabine
- +9 more
-
Shanghai, Shanghai, ChinaCancer Hospital Affiliated to Fudan University
May 19, 2020
Advanced Malignant Solid Tumor, Recurrent Ependymal Tumor, Recurrent Ewing Sarcoma Trial in Puerto Rico, United States
Active, not recruiting
- Advanced Malignant Solid Neoplasm
- +35 more
- Pharmacokinetic Study
- Ulixertinib
-
Birmingham, Alabama
- +108 more
Oct 19, 2022
Microbiota and Metabolites Alterations in Pancreatic Head and
Completed
- Pancreatic Ductal Adenocarcinoma (PDAC)
- 16S rRNA amplicon sequencing and untargeted metabolomics
-
Jinan, Shandong, ChinaQilu Hospital of Shandong University
Nov 27, 2023
Respiratory Failure Trial in Boston (Normoxia with Normocarbia, Normoxia with Hypercarbia, Hyperoxia with Normocarbia)
Terminated
- Respiratory Failure
- Normoxia with Normocarbia
- +3 more
-
Boston, MassachusettsBeth Israel Deaconess Medical Center
Mar 7, 2022
Obstructive Sleep Apnea, Obesity Trial in Prague (Dietary and physical intervention)
Recruiting
- Obstructive Sleep Apnea
- Obesity
- Dietary and physical intervention
-
Prague, CzechiaUniversity Hospital Královské Vinohrady
Feb 15, 2022
Depressive Disorder Trial in Tanta (Fluoxetine 20 mg, Dapagliflozin 10mg Tab, Atorvastatin 80mg)
Not yet recruiting
- Depressive Disorder
- Fluoxetine 20 mg
- +2 more
-
Tanta, Shebeen El-Kom, EgyptFaculty of Medicine, Menoufia University
Mar 19, 2023